Oxford Nanopore Technologies (LON:ONT – Get Free Report) had its price target decreased by equities research analysts at Berenberg Bank from GBX 230 to GBX 220 in a report released on Monday,Digital Look reports. The firm presently has a “buy” rating on the stock. Berenberg Bank’s target price points to a potential upside of 107.74% from the stock’s current price.
A number of other equities analysts have also recently weighed in on ONT. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a GBX 225 price target on shares of Oxford Nanopore Technologies in a report on Tuesday, May 26th. Citigroup lowered Oxford Nanopore Technologies to a “buy” rating in a report on Friday. Four research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, Oxford Nanopore Technologies presently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 212.60.
Check Out Our Latest Research Report on ONT
Oxford Nanopore Technologies Trading Down 12.0%
Insider Activity at Oxford Nanopore Technologies
In other news, insider Nick Keher acquired 22,018 shares of Oxford Nanopore Technologies stock in a transaction that occurred on Monday, May 11th. The stock was purchased at an average cost of GBX 113 per share, with a total value of £24,880.34. Insiders purchased 22,799 shares of company stock worth $2,578,133 in the last three months. 2.54% of the stock is currently owned by insiders.
Oxford Nanopore Technologies Company Profile
Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.
See Also
- Five stocks we like better than Oxford Nanopore Technologies
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for Oxford Nanopore Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
